Biphenyl

Biphenyl

SCHEMBL3685922

c1ccc(-c2ccccc2)cc1.c1ccc2nocc2c1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 2/20 0.38
LMNA P02545 2/20 0.38
KMT2A Q03164 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
NR1H4 Q96RI1 1/20 0.38
TP53 P04637 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
PDE10A Q9Y233 1/20 0.37
KDM4E B2RXH2 2/20 0.36
PKM P14618 1/20 0.36
NOTUM Q6P988 3/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
ELANE P08246 1/20 0.36
MAPT P10636 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthalene SCHEMBL1879779 0.89 NPC1 (0.43) NPC1RAB9AALDH1A1MEN1KMT2A
Benzo[C]Isoxazole SCHEMBL1833459 0.89 RAB9A (0.43) NPC1RAB9AALDH1A1MEN1LMNA
Benzo[C]Isoxazole SCHEMBL27845401 0.89 NPC1 (0.43) NPC1RAB9AALDH1A1MEN1KMT2A
Benzo[C]Isoxazole SCHEMBL28208572 0.86 RAB9A (0.42) NPC1RAB9AALDH1A1MEN1LMNA
Benzo[C]Isoxazole SCHEMBL22579004 0.83 NPC1 (0.41) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL2491554 0.82 GAA (0.46) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL2491479 0.82 NPC1 (0.51) NPC1RAB9AALDH1A1MEN1KMT2A
Benzo[C]Isoxazole SCHEMBL23045175 0.79 NPC1 (0.38) NPC1RAB9AALDH1A1ESR1ESR2
Benzo[C]Isoxazole SCHEMBL11231055 0.79 RAB9A (0.41) NPC1RAB9AALDH1A1LMNAMAPK1
Benzo[C]Isoxazole SCHEMBL18486460 0.79 RAB9A (0.38) NPC1RAB9AALDH1A1PDE10AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318995-B2 Asymmetric pyrene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20100308718-A1 ASYMMETRIC PYRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-12-09 US disclosed
US-7763761-B2 Asymmetric pyrene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2010-07-27 US disclosed
US-20070042220-A1 Compound having spiro bond, material for luminescent coating formation and organic electroluminescence element including the same IDEMITSU KOSAN CO., LTD. (JP) 2007-02-22 US disclosed
EP-1749809-A1 ASYMMETRIC PYRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-02-07 EP disclosed
EP-1696708-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2006-08-30 EP disclosed
US-20060154107-A1 Asymmetric pyrene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2006-07-13 US disclosed
US-20060051613-A1 Material for organic electroluminescent device and organic electroluminescent device using same IDEMITSU KOSAN CO., LTD. (JP) 2006-03-09 US disclosed
EP-1623968-A1 COMPOUND HAVING SPIRO BOND, MATERIAL FOR LUMINESCENT COATING FORMATION AND ORGANIC ELECTROLUMINESCENCE ELEMENT INCLUDING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2006-02-08 EP disclosed
EP-1595933-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2005-11-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100308718-A1 ASYMMETRIC PYRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME ESR1, EBPL, JUP NPC1 3856/4885RAB9A 3295/4885ALDH1A1 1078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.